Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Antivirals, Including Antibody Products

These sections summarize the data on antiviral agents, including remdesivir, ritonavir-boosted nirmatrelvir, and anti-SARS-CoV-2 monoclonal antibodies.

Antivirals, Including Antibody Products Summary Recommendations

Read the Panel’s recommendations on the use of antiviral agents for the treatment of COVID-19 and for SARS-CoV-2 PrEP.

Remdesivir

Remdesivir is a nucleotide analogue prodrug that is approved to treat COVID-19 in certain patients.

Ritonavir-Boosted Nirmatrelvir (Paxlovid)

Read about using ritonavir-boosted nirmatrelvir in patients with COVID-19.

Molnupiravir

Read about using molnupiravir in patients with COVID-19.

Anti-SARS-CoV-2 Monoclonal Antibodies

These monoclonal antibodies target the spike protein and several are authorized to treat COVID-19.

COVID-19 Convalescent Plasma

Plasma from donors who have recovered from COVID-19 may contain SARS-CoV-2 antibodies.

Interferons

Interferons are a group of antiviral cytokines that are being evaluated to treat COVID-19.

Table: Characteristics of Antiviral Agents, Including Antibody Products

Review the characteristics of the antiviral agents that are under evaluation for the treatment of COVID-19 or for SARS-CoV-2 PrEP.